Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lindsay Dohany"'
Autor:
Fatih Z Boyar, Kylin Y. Lammers, Loretta W Mahon, Nicole Truitt, Arturo Anguiano, Lindsay Dohany, Boris T Wang
Publikováno v:
Open Journal of Obstetrics and Gynecology. 10:1122-1134
Objectives: This retrospective study evaluated 1) benefits of single nucleotide polymorphism (SNP)-based chromosomal microarrays (CMAs) in the diagnosis of complete hydatidiform mole (CHM) and partial HM (PHM) in products of conception (POC) and amni
Publikováno v:
Cancer Research. 80:P6-08
Background: Hereditary cancer risk assessment is standard of care in the obstetrics and gynecology (ob/gyn) practice. Historical data indicates 1 in 12 individuals have a family history consistent with hereditary cancer(1), however recent data from a
Autor:
Ryan E. Longman, Carol Holland, Catherine Terhaar, Nicole Teed, Lindsay Dohany, Rachel Allen, Christina Settler
Publikováno v:
Prenatal Diagnosis
Objectives Expanded carrier testing is acknowledged as an acceptable strategy for carrier testing by the American College of Obstetrics and Gynecology. Limited studies have investigated positivity rates of expanded carrier panels. We describe our exp
Autor:
Christina Settler, Ryan E. Longman, Jeana DaRe, Tobias Mann, Carol Holland, Kailey M. Owens, Lindsay Dohany
Publikováno v:
American Journal of Medical Genetics Part A. 176:1304-1308
Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and is caused by an expansion of cytosine-guanine-guanine (CGG) repeats in the FMR1 gene. Female premutation allele carriers (55-200 CGG repeats) are at risk to ha
Autor:
Nicholas Wisniewski, Stephanie Woods, Heidi Owen, Lindsay Dohany, Michele Basiliere, Lisa McDaniel
Publikováno v:
Journal of Clinical Oncology. 39:10579-10579
10579 Background: The clinical utility of hereditary cancer multigene testing is well-established. Most testing has been performed in the White European population, with a relative shortage of data in other ethnic groups. Evaluation of hereditary can
Autor:
Heidi Dreyfuss, Dana Zakalik, Otavio Pereira-Rodrigues, Jennifer Fulbright, Ashley Reeves, Siddhartha Yadav, Lindsay Dohany
Publikováno v:
Cancer Research. 75:P4-12
Introduction: BRCA 1 and 2 testing has been widely incorporated into clinical care for women at risk for hereditary breast cancer. Knowledge of BRCA mutation status prior to surgery may influence decision regarding type of surgery. This study analyze
Autor:
Jennifer Fulbright, Sarah Mange, Lindsay Dohany, Dana Zakalik, Debra Duquette, Nancie Petrucelli
Publikováno v:
Journal of Genetic Counseling. 24:285-293
This study determined the prevalence of non-Ashkenazi Jewish BRCA1/2 mutations in the Ashkenazi Jewish population in the state of Michigan, current provider testing practices, and the use of mutation probability models in determining which Ashkenazi
Autor:
Jeana DaRe, Craig Adamski, Lindsay Dohany, Christina Settler, Catherine Terhaar, Priscilla Fernandes
Publikováno v:
Obstetrics & Gynecology. 133:163-163
Publikováno v:
Cancer Research. 70:P2-10
BACKGROUND: Breast cancer patients with BRCA 1 or 2 gene mutations demonstrate a high lifetime incidence of a second breast cancer in the contralateral breast. These patients may benefit from a bilateral mastectomy (BLM) with an intent of risk reduct
Publikováno v:
Obstetrics & Gynecology. 131:176S-176S